You are viewing: Malaysia ASEAN Point of Care Diagnostics Market analysis

The Malaysia ASEAN Point of Care Diagnostics Market was valued at $150.81 Million in 2025 and projected to reach to $187.25 Million by 2030, representing a compound annual growth rate of 4.4%. Malaysia's point of care diagnostics market is poised for sustained growth, driven by increasing healthcare spending, rising prevalence of chronic diseases, and growing consumer preference for convenient, rapid testing solutions.

Malaysia ASEAN Point of Care Diagnostics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Malaysia ASEAN Point of Care Diagnostics Market Trends and Insights

  • Malaysia's healthcare infrastructure and rising demand for rapid diagnostic solutions are driving adoption across clinical and non-clinical settings.
  • The market in Malaysia reflects broader ASEAN trends toward decentralized testing and improved patient outcomes through faster turnaround times. In Malaysia, point of care diagnostics are increasingly integrated into primary care facilities, emergency departments, and home-based testing programs.
  • Malaysia's regulatory environment and healthcare investment initiatives support market expansion through 2030.
  • The growth trajectory in Malaysia is underpinned by aging demographics, chronic disease prevalence, and healthcare provider emphasis on efficiency and accessibility..

Key Market Statistics

  • CAGR (2025-2030) 4.4% CAGR
  • Market Size, 2025 ~USD 150.81 Million
  • Forecast, 2030 ~USD 187.25 Million
  • Country Malaysia

Malaysia ASEAN Point of Care Diagnostics Market Overview

Market Valuation :

Malaysia's point of care diagnostics market is valued at USD 150.81 million in 2025, with strong growth trajectory positioning it as a key market within ASEAN.

Growth Momentum :

The market is expanding at a CAGR of 4.4% from 2025 to 2030, outpacing broader healthcare diagnostics trends and reflecting increasing adoption of rapid testing solutions.

Healthcare Infrastructure Development :

Malaysia's advancing healthcare infrastructure and government initiatives to modernize diagnostic capabilities are accelerating point of care testing adoption across urban and emerging healthcare facilities.

Clinical & Non-Clinical Expansion :

Rising demand for rapid diagnostic solutions is driving adoption across both clinical settings (hospitals, clinics) and non-clinical environments (pharmacies, workplaces, home care), broadening market reach.

Malaysia ASEAN Point of Care Diagnostics Market Dynamics

  • The market's expansion from USD 150.81 million in 2025 to USD 187.25 million by 2030 reflects strong demand across multiple segments and settings. Key growth catalysts include government healthcare modernization initiatives, rising awareness of preventive diagnostics, and expanding distribution networks in both urban and rural areas.
  • Malaysia's strategic position within ASEAN and its developed healthcare ecosystem position it favorably for continued market expansion, with opportunities emerging in infectious disease testing, chronic disease management, and point of care laboratory consolidation..

Related Ecosystem

Key Takeaways

  • Malaysia's point of care diagnostics market is valued at USD 150.81M in 2025 and will reach USD 187.25M by 2030 at 4.4% CAGR.
  • Malaysia's healthcare system is increasingly adopting decentralized diagnostic testing to improve accessibility and reduce diagnostic turnaround times.
  • Chronic disease management and aging population demographics are key growth drivers for point of care diagnostics adoption in Malaysia.
  • Malaysia's regulatory framework and healthcare modernization initiatives create favorable conditions for market expansion through 2030.

ASEAN Point of Care Diagnostics Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment RESPIRATORY INFECTION TESTING PRODUCTS (Disease Type)
Forecast Period 2025-2030
Growth Rate CAGR of 4.7% from 2025 to 2030
Largest Segment BIOCHEMISTRY (Technology)
Market Size Base Year (Billions) ~USD 1.08 (2025)
Revenue Forecast (Billions) ~USD 1.36 (2030)
Segments Covered Product, Type, Disease Type, Technology, End User

Malaysia ASEAN Point of Care Diagnostics Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

  • Cancer Marker Testing Products
  • Cardiometabolic Testing Products
  • Cholesterol Testing Products
  • Coagulation Monitoring Products
  • Drugs-Of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Glucose Monitoring Products
  • Hematology Testing Products
  • Infectious Disease Testing Products
  • Other Poc Products
  • Pregnancy & Fertility Testing Products
  • Urinalysis Testing Products

By Type

  • Blood Gas & Electrolyte Testing Products
  • Cardiac Marker Testing Products
  • Glucometers
  • Glucose Test Strips
  • Hba1C Testing Products
  • Hepatitis B Testing Products
  • Hepatitis C Testing Products
  • Influenza Testing Products
  • Lancets
  • Other Respiratory Infection Testing Products
  • Tb Testing Products

By Disease Type

  • Hai Testing Products
  • Hepatitis Testing Products
  • Hiv Testing Products
  • Hospital-Acquired Infection Testing Products
  • Mosquito-Borne Disease Testing Products
  • Other Infectious Disease Testing Products
  • Respiratory Infection Testing Products
  • Std Testing Products

By Technology

  • Biochemistry
  • Lateral Flow Assays (Immunoassays)
  • Rapid Tests (Molecular Diagnostics)

By End User

  • Clinical Laboratories
  • Home Care Settings
  • Hospitals And Critical Care Centers
  • Other End Users
  • Outpatient Settings And Ambulatory Care Centers

MALAYSIA: ASEAN POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2022–2030

Segment20222023202420252026202820292030CAGR (%)
CLINICAL LABORATORIES52.6852.7753.253.9955.0558.2860.5163.223.2
HOME CARE SETTINGS63.3164.7166.66971.8579.4184.2990.055.5
HOSPITALS AND CRITICAL CARE CENTERS14.4114.6114.9215.3415.8417.2318.1519.234.6
OTHER END USERS4.094.064.054.084.124.284.414.572.3
OUTPATIENT SETTINGS AND AMBULATORY CARE CENTERS8.068.128.238.48.629.249.6710.173.9
TOTAL142.56144.27147150.81155.47168.45177.02187.254.4

Target Audience

  • Diagnostic Device Manufacturers : Manufacturers need Malaysia-specific market data to assess market size, growth potential, and competitive dynamics for product launches, localization strategies, and distribution partnerships in this high-growth ASEAN market.
  • Healthcare Investors & PE Firms : Investors require detailed Malaysia market analysis to evaluate investment opportunities in POC diagnostics companies, healthcare infrastructure, and diagnostic service providers with clear growth trajectories and ROI potential.
  • Hospital & Clinic Operators : Healthcare facility operators need market insights to understand POC diagnostics adoption trends, technology preferences, and procurement patterns to optimize diagnostic service offerings and operational efficiency.
  • Pharmaceutical & Biotech Companies : Companies developing diagnostic solutions need Malaysia-specific market intelligence to identify unmet clinical needs, regulatory pathways, and commercialization strategies for rapid diagnostic products.
  • Healthcare Consultants & Advisors : Consultants advising healthcare organizations require country-level market data to develop strategic recommendations, competitive analyses, and market entry strategies specific to Malaysia's POC diagnostics landscape.

Reasons to Buy this Report

  • Market-Specific Sizing & Forecasts : Access precise valuation data for Malaysia's POC diagnostics market (USD 150.81M in 2025, USD 187.25M in 2030) with country-specific CAGR of 4.4%, enabling accurate business planning and investment decisions.
  • Competitive Landscape Intelligence : Understand Malaysia-specific market dynamics, key players, and competitive positioning within the ASEAN region to identify partnership and expansion opportunities tailored to local market conditions.
  • Segment & Application Insights : Gain detailed breakdown of Malaysia's POC diagnostics adoption across clinical and non-clinical settings, including hospitals, clinics, pharmacies, and home care environments for targeted market entry strategies.
  • Growth Driver Analysis : Identify Malaysia-specific growth catalysts including healthcare infrastructure development, government initiatives, and rising demand for rapid diagnostic solutions to capitalize on emerging opportunities.
  • Strategic Decision Support : Leverage country-level market intelligence to inform product development, pricing strategies, distribution partnerships, and market entry timing specific to Malaysia's healthcare ecosystem and regulatory environment.

Frequently asked questions

What is the current market size of point of care diagnostics in Malaysia?

Malaysia's point of care diagnostics market is valued at USD 150.81 million in 2025 according to verified market data.

What is the projected market size for Malaysia by 2030?

Malaysia's point of care diagnostics market is forecast to reach USD 187.25 million by 2030, representing a 4.4% compound annual growth rate.

What factors are driving growth in Malaysia's point of care diagnostics market?

Key drivers in Malaysia include rising chronic disease prevalence, an aging population, healthcare provider focus on efficiency, and government healthcare modernization initiatives.

Which healthcare settings in Malaysia are adopting point of care diagnostics?

In Malaysia, point of care diagnostics are being integrated into primary care facilities, emergency departments, clinics, and home-based testing programs.

How does Malaysia's market growth compare to the broader ASEAN region?

Malaysia's 4.4% CAGR is slightly below the global ASEAN average of 4.7%, reflecting a mature but steady market with strong healthcare infrastructure.

RESEARCH METHODOLOGY

The study involved major activities in estimating the current market size for the ASEAN point of care diagnostics market. Exhaustive secondary research was done to collect information on the ASEAN point of care diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ASEAN point of care diagnostics market.

The four steps involved in estimating the market size are:

Secondary Research

In the secondary research process, various secondary sources, such as company annual reports, press releases, and investor presentations, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were referred to identify and collect information for this study.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

The following is a breakdown of the primary respondents:

Asean Point of Care Diagnostics Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
PTS Diagnostics Regional Sales Manager
EKF Diagnostics Holdings plc Product Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the ASEAN point of care diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • Primary and secondary research has determined the revenues of leading players operating in the ASEAN point of care diagnostics market.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

The research methodology used to estimate the market size includes the following:

Asean Point of Care Diagnostics Market

Data Triangulation

After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Point of care testing (POCT) includes tests designed to be used at or near the patient's site (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid & reliable diagnostic testing to obtain outcomes instantly, helping physicians/patients make care decisions remotely and rapidly.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department  
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the ASEAN point of care diagnostics market based on product, technology, end user, and country
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall ASEAN point of care diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to ten countries, namely, Vietnam, Laos, Cambodia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Indonesia, and Brunei
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business & product excellence

Get the Full ASEAN Point of Care Diagnostics Market Report

Full forecast, segment splits, and company analysis for all ASEAN Point of Care Diagnostics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status